Shahrokh Javaheri, MD
Sleep Medicine · Cincinnati, OHNPI 1407829757
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by ZOLL Respicardia, Inc. at 50.4% of the total. Reporting peaked in 2023 at $115,108 and has fallen 59.2% since, to $46,967 in 2025. Among sleep medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 362 payments — averaging $1114.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Respicardia, Inc.$204K
- Idorsia Pharmaceuticals US Inc$123K
- Jazz Pharmaceuticals Inc.$23K
- Avadel CNS Pharmaceuticals, LLC$19K
- Fisher & Paykel Healthcare Limited$13K
- Philips North America LLC$8K
- plus $14K from 14 others
What the payments were for
- Consulting fees$188,55847%
- Speaking & faculty fees$174,31843%
- Travel & lodging$27,7937%
- Food & beverage$12,3903%
- Education$5430%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Respicardia, Inc. | 47 | $203,530 |
| Idorsia Pharmaceuticals US Inc | 112 | $123,061 |
| Jazz Pharmaceuticals Inc. | 56 | $23,489 |
| Avadel CNS Pharmaceuticals, LLC | 31 | $18,656 |
| Fisher & Paykel Healthcare Limited | 5 | $12,997 |
| Philips North America LLC | 4 | $7,910 |
| Merck | 11 | $6,685 |
| Harmony Biosciences LLC | 29 | $2,636 |
| Eisai Inc. | 1 | $1,700 |
| Eli Lilly | 1 | $800 |
| Axsome Therapeutics, Inc. | 17 | $610 |
| Inspire Medical Systems, Inc. | 19 | $509 |
| Novo Nordisk | 7 | $279 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $223 |
| Avita Medical Americas, LLC | 1 | $176 |
| Lilly USA, LLC | 8 | $138 |
| Fisher & Paykel Healthcare Inc | 5 | $97 |
| Resmed Corp | 2 | $40 |
| Itamar Medical Inc | 1 | $37 |
| Vanda Pharmaceuticals Inc. | 2 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- remede System$203,414
- QUVIVIQ$121,846
- LUMRYZ$18,175
- XYWAV$16,578
- XYREM$15,089
- Obstructive Sleep Apnea Device or Hospital Respiratory Equipment$12,936
- US Enabling function$7,818
- Wakix$2,009
- SUNOSI$1,510
- RECELL$176
- Wegovy$125
How this compares
$403,602 in reported general payments places this provider in the 95th percentile of 94 sleep medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Armodafinil | 13 | $947 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Cincinnati
- Anthony SuchoskiCincinnati$89K
- Shayla PullenCincinnati$71K
- Sunil DamaCincinnati$7K
- Omdevasena ThirugnanamCincinnati$7K
- Karthikeyan KanagarajanCincinnati$6K
- Chiranjeevi Pramodna SiddaguntaCincinnati$3K
- Bashar BrijawiCincinnati$3K
- Ann RomakerCincinnati$2K
- Roma UyCincinnati$1K
- Asim RoyDublin$666K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.